Jens Hasskarl

Chief Medical Officer • Tigen Pharma

Given track record across multiple Cell & Gene Therapy Clinical Development programs in what is now Kymriah®, Breyanzi®, and Abecma®, with the most recent approvals of Breyanzi® in 2nd line DLBCL.

Prior Experience


  • Executive Medical Director, Program Lead Global Clinical Research and Development GCR&D CAR -T
  • Head Europe Cellular Therapy Clinical Center of Expertise


  • Senior Global Clinical Leader, CTL019 Lymphoma
  • A. i. Global Clinical Program Head, CTL019 Lymphoma

Academic Career

  • Board certification in internal medicine, hematology
    and oncology
  • Group leader at University Hospital Freiburg, Germany
  • Venia legendi internal medicine and private lecturer


  • Postdoctoral fellow at Harvard Medical School, Boston, MA
  • German Cancer Research Center, Heidelberg, Germany
  • Medical Schools in Freiburg, Germany, Vienna, Austria, Heidelberg, Germany, and Harvard Medical School, Boston, MA, USA, Stipend of Biomedical Exchange Program (BMEP)

Also speaking

Allison Blair

Head of Laboratory • NHS Blood and Transplant

Nicholas Medcalf

Deputy Challenge Director for the Medicines Manufacturing Challenge • Innovate UK

Ohad Karnieli

Founder & CEO • Adva Biotechnology

Event Info


Spotlight Roundtables

Take a look at the sample attendee list for Advanced Therapies Europe here.

Pub & Pints RSVP

Let us know you’re planning on attending.